Journal list Promote Sponsor
verified SJR 2,167 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Neoplasia
United States · Elsevier Inc.
workspace_premium Q1 — Cancer Research visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Neoplasia

Neoplasia is a journal indexed in SJR in Cancer Research with an H index of 147. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cancer, tumors, oncology research, medicine. It has an SJR impact factor of 2,167 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,167.

Neoplasia focuses its scope in these topics and keywords: gene, breast, promotes, gastric, cancer, cell, modifications, malignant, mmtvneut, perspective, ...

ISSN: 1522-8002
Publisher: Elsevier Inc.
Category: Cancer Research
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
2,167 Q1
H-index 147
Acceptance rate pie_chart
22% Selective
Source Acceptance_Rate
Time to publication hourglass_top
12 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.250 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

2,167

H-index

147

Docs (year)

108

Docs 3y

288

Total refs

5208

Cites 3y

1963

Citable 3y

286

Cites/Doc 2y

7.95

Ref/Doc

48.22

Immediate OA

2250 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Neoplasia profile: American Institute for Cancer Research

View more

Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models

View more

The V Foundation for Cancer Research

View more

The National Brain Tumor Foundation: Giving Help, Giving Hope

View more

The International Myeloma Foundation

View more

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

View more

The G&P Foundation for Cancer Research

View more

The Cure for Lymphoma Foundation

View more

The Association for International Cancer Research

View more

Profile - American Cancer Society

View more

Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors

View more

Neoplasia: Where We Have Been and Where We Are Going

View more
SHOW MORE ARTICLES

Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer

View more

National Foundation for Cancer Research

View more

National Childhood Cancer Foundation

View more

Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1

View more

Kidney Cancer Association

View more

Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

View more

Implications of Mapping the Human Telomerase Gene (hTERT) as the Most Distal Gene on Chromosome 5p

View more

Editorial

View more

Concern Foundation: Funding Cancer Research Worldwide

View more

Art Of The Brain: UCLA Neuro-Oncology Program

View more

American Brain Tumor Association: Sharing Knowledge, Sharing Hope

View more

FAQs